<ѻý>Cancer Immunotherapy Tied to Severe COVID-19 Outcomesѻý> Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
<ѻý>Worse Blood Cancer Outcomes in Hispanicsѻý> Diagnosis at earlier age, worse survival, especially for those on U.S.-Mexico border Jun 24, 2020
<ѻý>Endoscopic Procedure Wins in Early Stomach Cancerѻý> In the U.S. and Canada, curative resection high, recurrence low -- and learning curve steep Jun 22, 2020
<ѻý>Combination Ups Survival in Older AML Patientsѻý> Frontline venetoclax plus azacitidine adds 5 months to median OS versus azacitidine alone Jun 17, 2020
<ѻý>Biologic Effective in Light Chain Amyloidosisѻý> Anti-CD38 therapy added to conventional regimen boosts PFS in trial Jun 16, 2020
<ѻý>Keytruda Tops Adcetris in Head-to-Head Hodgkin's Trialѻý> Checkpoint inhibitor improved PFS in refractory and transplant-ineligible cases Jun 15, 2020
<ѻý>New Standard for Relapsed/Refractory Multiple Myeloma?ѻý> Triplet regimen significantly extended median PFS versus doublet in IKEMA study Jun 15, 2020
<ѻý>High Marks for CAR T Cells in R/R Myelomaѻý> Response rates of 70-100% with BCMA-targeted products for heavily treated disease Jun 03, 2020
<ѻý>Second Surgery Gets OS Win in Recurrent Ovarian Cancerѻý> Survival improved by nearly 8 months with cytoreductive surgery at first relapse Jun 02, 2020
<ѻý>Early Palliation: Boon for AML Patients on Intensive Chemoѻý> Intervention led to marked improvements in QoL, mental distress, end-of-life care Jun 02, 2020
<ѻý>Pembrolizumab May Help in Triple-Negative Breast Cancerѻý> Upfront therapy extends progression-free survival in metastatic disease, study shows Jun 01, 2020
<ѻý>Surgery for Metastatic Breast Cancer Fails to Boost Overall Survivalѻý> Cumulative data, though, don't rule out benefit for selected patients with de novo stage IV disease Jun 01, 2020
<ѻý>Add-On Tucatinib Ups Survival in Breast Cancer With Brain Metsѻý> TKI plus trastuzumab-capecitabine reduced risk of death by nearly half Jun 01, 2020
<ѻý>VRd Still Reigns in Newly Diagnosed Myelomaѻý> KRd fails to prove superiority in head-to-head trial Jun 01, 2020
<ѻý>CAR T-Cell Therapy Impresses in Indolent NHLѻý> Overall response rate exceeding 90% with axi-cel in relapsed/refractory setting May 31, 2020
<ѻý>Oral ADT Slashes Heart Risk in Advanced Prostate Cancerѻý> Novel GnRH antagonist has potential to be new standard, says researcher May 30, 2020
<ѻý>Studies Make Case for Hormonal Therapy in nmCRPCѻý> Prolonged survival with three different androgen signaling inhibitors May 30, 2020
<ѻý>HCQ Linked to Harm in Cancer Patientsѻý> Combination with azithromycin associated with three-fold risk of mortality, registry study shows May 28, 2020
<ѻý>New First-Line Standard in Metastatic Bladder Cancerѻý> "High bar to beat" as avelumab maintenance improves median survival by over 7 months May 28, 2020
<ѻý>Paradigm Shift Coming for Early NSCLC?ѻý> Postoperative osimertinib doubles DFS in patients with stages Ib-IIIa EGFR+ lung cancer May 28, 2020
<ѻý>End of Life and COVID-19; DCIS Doubles Cancer Risk; Training for 'Bad News'ѻý> News, features, and commentary about cancer-related issues May 28, 2020
<ѻý>New Clue to Anti-PD-L1 Activity in Breast Cancer?ѻý> Survival benefit with durvalumab in patients with PDL1 copy number alteration May 26, 2020
<ѻý>Biologics Don't Increase Melanoma Risk... Probablyѻý> Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
<ѻý>Avelumab Flops Again in Ovarian Cancerѻý> Another negative phase III trial, now in the first-line setting May 19, 2020
<ѻý>PARP Inhibitors Still Work in HRD-Low Ovarian Cancerѻý> In VELIA, homologous recombination deficiency score prognostic but not predictive May 14, 2020
<ѻý>KRAS May Predict Benefit of MEK Inhibitors in Some Ovarian Cancersѻý> Nearly 7-month PFS boost in patients with KRAS mutations May 11, 2020
<ѻý>Five Days of G-CSF Adequate for Breast Cancer Chemoѻý> Rate of chemotherapy-induced febrile neutropenia similar to 7- to 10-day regimen May 08, 2020
<ѻý>Face-Aging Selfies Help Modify Risky Skin Behaviors for Teensѻý> Trial looked at effects of a free "UV-selfie" app May 07, 2020
<ѻý>BMI, Weight Change Linked to Prostate Ca Outcomesѻý> Gain or loss of body weight both show risk May 07, 2020
<ѻý>Blood Test Promising as Colorectal Cancer Screenѻý> In early study, better numbers than with current alternatives to colonoscopy May 07, 2020
<ѻý>Ranitidine Cancer Risk: Health Records Offer Reassuranceѻý> Huge study finds no indication that nitrosamine contamination affected real-world outcomes May 05, 2020
<ѻý>Honing Chemo Use in Small Breast Tumorsѻý> Clearest survival benefit for 8-10 mm tumors in HR/HER2-positive disease May 03, 2020
<ѻý>Nivolumab-Based Tx Effective in Early, Unfavorable Hodgkin'sѻý> Interim results showed high CR rates and almost 100% PFS, OS at 12 months May 01, 2020
<ѻý>6-Week Keytruda Safe, Effective in Melanomaѻý> Schedule gets FDA approval for all adult indications Apr 30, 2020
<ѻý>Talzenna Misses OS Endpoint in BRCA-Positive Breast Cancerѻý> But PARP inhibitor improved patient-reported outcomes over standard therapy Apr 29, 2020
<ѻý>COVID-19 Mortality Spikes in Patients With Lung, Blood Cancersѻý> Those with metastatic disease also at special risk for poor outcomes Apr 28, 2020
<ѻý>Anti-PD-L1 Plus PARP Inhibitor Ups Response in Breast Cancerѻý> Add-on treatment superior to chemo alone, but questions remain about cost, toxicity Apr 28, 2020
<ѻý>Triplet Succeeds in BRAF-Mutant Melanomaѻý> Immunotherapy plus BRAF/MEK inhibition boosts PFS over targeted agents alone Apr 27, 2020